Patents by Inventor James W. Patrick

James W. Patrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5591590
    Abstract: The present invention relates to a family of neuronal nicotinic acetylcholine receptors comprised of neuronal agonist and non-agonist binding subunits, and DNA sequences encoding such subunits. These novel neuronal nicotinic acetylcholine receptor subunits include the agonist binding subunits alpha2, alpha3, alpha4, and alpha5, plus non-agonist binding subunits beta2, beta3 and beta4. Representative cDNA clones that contain the DNA sequences of the invention have been deposited with the American Type Culture Collection for patent purposes.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 7, 1997
    Assignee: The Salk Institute for Biological Studies
    Inventors: Stephen F. Heinemann, James W. Patrick, James R. Boulter, Evan S. Deneris, John G. Connolly, Robert M. Duvoisin, Eden D. Heinemann, Keiji Wada, Marc C. Ballivet, Daniel J. Goldman
  • Patent number: 5449606
    Abstract: The present invention discloses a new neuronal nicotinic acetylcholine receptor subunit, .beta.4. The new subunit can form functional combinations with other neuronal nicotinic acetylcholine receptor subunits, including, but not limited to, alpha2, alpha3, alpha4 and beta2. A cDNA clone containing the DNA sequences that encode the novel receptor subunit of the invention has been deposited with the American Type Culture Collection for patent purposes.
    Type: Grant
    Filed: May 6, 1993
    Date of Patent: September 12, 1995
    Assignee: The Salk Institute for Biological Studies
    Inventors: Stephen F. Heinemann, Robert M. Duvoisin, Evan S. Deneris, James W. Patrick
  • Patent number: 5371188
    Abstract: The present invention relates to a family of neuronal nicotinic acetylcholine receptors comprised of neuronal agonist and non-agonist binding subunits, and DNA sequences encoding such subunits. These novel neuronal nicotinic acetylcholine receptor subunits include the agonist binding subunits alpha2, alpha3, alpha4, and alpha5, plus non-agonist binding subunits beta2, beta3 and beta4. Representative cDNA clones that contain the DNA sequences of the invention have been deposited with the American Type Culture Collection for patent purposes.
    Type: Grant
    Filed: June 12, 1992
    Date of Patent: December 6, 1994
    Assignee: The Salk Institute for Biological Studies
    Inventors: Stephen F. Heinemann, James W. Patrick, James R. Boulter, Evan S. Deneris, Keiji Wada, Marc C. Ballivet, Daniel J. Goldman, John G. Connolly, Robert M. Duvoisin, Eden D. Heinemann
  • Patent number: 5115650
    Abstract: A knit pattern for fabrics which will not run when the fabric is torn or snagged. The knit pattern provides non-run pantyhose when use to knit pantyhose for women. The knit pattern consists of four repeating courses. The first course alternates a face loop stitch with a tuck stitch. The second course alternates a face loop stitch with a tuck stitch, with each face loop stitch of the first course being in the same column as each tuck stitch of the third course, and each tuck stitch of the first course being in the same column as each face loop stitch of the third course. The fourth course is knit into continuous face loop stitches.
    Type: Grant
    Filed: June 11, 1990
    Date of Patent: May 26, 1992
    Assignee: Sheer Lady International, Inc.
    Inventors: Alvin J. Patrick, Willie H. Patrick, deceased, James W. Patrick, administrator
  • Patent number: 5066593
    Abstract: A sequence in the coat glycoprotein of rabies virus is identified as the molecular basis for an essential step in the pathogenesis of the virus, the binding of virus to acetylcholine receptor at neuromuscular junctions prior to virus uptake into peripheral nerves. Based on this discovery, synthetic peptide-based, anti-rabies vaccines are prepared. The active ingredient of such vaccines is a synthetic protein, which is a conjugate with an immunogenic carrier protein of a synthetic peptide with a sequence which includes a sequence which is substantially the same as a substantial portion of the sequence of the acetylcholine receptor-binding segment of the rabies virus coat protein. Anti-rabies antisera, and anti-rabies antibodies, are prepared by injecting a mammal with a synthetic protein of the invention in a manner that induces an immune response in the mammal against the synthetic protein.
    Type: Grant
    Filed: August 31, 1987
    Date of Patent: November 19, 1991
    Assignee: The Salk Insstitute for Biological Studies
    Inventors: James W. Patrick, Stephen F. Heinemann, Barbara D. Boss, W. Maxwell Cowan
  • Patent number: 4865968
    Abstract: A first mixture is prepared that contains labeled chain fragments which each has a common end adjacent to a primary nucleotide and a termination at a position from the primary through an nth nucleotide, the first mixture containing nucleotide chain fragments of each length from termination at the primary through termination of the nth nucleotide. A second mixture is prepared that contains labeled chain fragments beginning at the common end and terminating at positions from the first through the nth nucleotide, the second mixture containing chain fragments of each length terminating wherever either a first or a second of the four nucleotides occurs. A third mixture is prepared that contains labeled chain fragments beginning at the common end and terminating at a position from the first through the nth nucleotide, the third mixture containing chain fragments of each length terminating wherever the first or a third of the four nucleotide sequences occurs.
    Type: Grant
    Filed: April 10, 1985
    Date of Patent: September 12, 1989
    Assignee: The Salk Institute for Biological Studies
    Inventors: Leslie E. Orgel, James W. Patrick
  • Patent number: 4707356
    Abstract: A sequence in the coat glycoprotein of rabies virus is identified as the molecular basis for an essential step in the pathogenesis of the virus, the binding of virus to acetylcholine receptor at neuromuscular junctions prior to virus uptake into peripheral nerves. Based on this discovery, synthetic peptide-based, anti-rabies vaccines are prepared. The active ingredient of such vaccines is a synthetic protein, which is a conjugate with an immunogenic carrier protein of a synthetic peptide with a sequence which includes a sequence which is substantially the same as a substantial portion of the sequence of the acetylcholine receptor-binding segment of the rabies virus coat protein. Anti-rabies antisera, and anti-rabies antibodies, are prepared by injecting a mammal with a synthetic protein of the invention in a manner that induces an immune response in the mammal against the synthetic protein.
    Type: Grant
    Filed: December 12, 1986
    Date of Patent: November 17, 1987
    Assignee: The Salk Institute for Biological Studies
    Inventors: James W. Patrick, Stephen F. Heinemann, Barbara D. Boss, W. Maxwell Cowan
  • Patent number: 4652629
    Abstract: A sequence in the coat glycoprotein of rabies virus is identified as the molecular basis for an essential step in the pathogenesis of the virus, the binding of virus to acetylcholine receptor at neuromuscular junctions prior to virus uptake into peripheral nerves. Based on this discovery, synthetic peptide-based, anti-rabies vaccines are prepared. The active ingredient of such vaccines is a synthetic protein, which is a conjugate with an immunogenic carrier protein of a synthetic peptide with a sequence which includes a sequence which is substantially the same as a substantial portion of the sequence of the acetylcholine receptor-binding segment of the rabies virus coat protein. Anti-rabies antisera, and anti-rabies antibodies, are prepared by injecting a mammal with a synthetic protein of the invention in a manner that induces an immune response in the mammal against the synthetic protein.
    Type: Grant
    Filed: July 3, 1985
    Date of Patent: March 24, 1987
    Assignee: The Salk Institute for Biological Studies
    Inventors: James W. Patrick, Stephen F. Heinemann, Barbara D. Boss, W. Maxwell Cowan
  • Patent number: 4368578
    Abstract: An orbital mission planning indicator device provides a visual indication of the relationship between the plane of orbit of an artificial earth satellite and the angle of incidence of solar energy thereon, for all seasons of the year and for arbitrary times and places of launch of such satellite. It also provides indications of the relationship of deep space points of interest to the same orbital plane for adaptability of pointable sensors such as telescopes, antennas and solar arrays to orbital missions calling for use of such equipments.
    Type: Grant
    Filed: November 23, 1979
    Date of Patent: January 18, 1983
    Assignee: Rockwell International Corporation
    Inventors: William J. Carroll, James W. Patrick